RSS

chronic thromboembolic pulmonary hypertension (CTEPH)

The Food and Drug Administration (FDA) has granted Breakthrough Device Designation to artificial intelligence software for chronic thromboembolic pulmonary hypertension (CTEPH) pattern recognition. Read more

North America